Prospective randomised phase II study of gemcitabine at standard or fixed dose rate schedule in unresectable hepatocellular carcinoma

por Guan, Z, Wang, Y, Maoleekoonpairoj, S, Chen, Z, Kim, W S, Ratanatharathorn, V, Reece, W H H, Kim, T W, Lehnert, M
Publicado 2003